本周封面故事 | 一针治百病？揭秘GLP-1药物的惊人效果与潜在革命

文章预览

 1 写在前面 本文介绍了GLP-1受体激动剂（如Ozempic和Wegovy）的革命性突破。这类药物最初用于治疗糖尿病和肥胖症，现在被发现对心血管疾病、肾病、阿尔茨海默症和成瘾等多种疾病也有潜在效果。文章探讨了这类药物广泛应用的原因，以及它们可能带来的巨大社会经济影响。作者强调，虽然GLP-1药物前景光明，但仍需更多长期研究来确认其效果和副作用。 2 精读|翻译|词组 Cover Story How we chose this week’s image We had one worldwide cover this week. And it featured some very good news. GLP-1 receptor agonists such as Ozempic and Wegovy started as treatments for diabetes and obesity. That alone would have qualified them as wonder drugs. Now they are being found to help with cardiovascular and kidney disease, too, and are being tested for use against Alzheimer’s and addiction. Researchers are even talking, in hushed tones, of their anti-ageing effects. They may t ………………………………